Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06269926 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Therapy for Chronic Pain in Adults With Cerebral Palsy
A NA study of Cerebral Palsy and Pain, Chronic, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- Active
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT06269926: Active NA study of Cerebral Palsy and Pain, Chronic, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
NCT06269926 is a NA study of Cerebral Palsy and Pain, Chronic that is active but no longer recruiting, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 14 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06269926, a NA study of Cerebral Palsy and Pain, Chronic, is active but no longer recruiting, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand if cognitive behavioral therapy can feasibly be provided to groups of adults with cerebral palsy and chronic pain via virtual group therapy sessions.
Primary Outcome
We will examine the rate of survey completion for each survey (0 = survey incomplete, 1 = survey complete). Higher scores indicate a better outcome (greater feasibility of recruiting adults with CP and chronic pain and retaining their engagement to complete this clinical trial over a period of 12 months).
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy for Chronic Pain
Study Locations (1)
Maryland
- Kennedy Krieger Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2025-02-27 |
| Est. Completion | 2027-02 |
| Phase | NA |
What the registry record for NCT06269926 still lists
NCT06269926 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy for Chronic Pain is the first listed.
NCT06269926 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06269926 about?
NCT06269926 is a clinical study titled "Cognitive Behavioral Therapy for Chronic Pain in Adults With Cerebral Palsy". The purpose of this study is to understand if cognitive behavioral therapy can feasibly be provided to groups of adults with cerebral palsy and chronic pain via virtual group therapy sessions.
What is the current status of trial NCT06269926?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2025-02-27. Estimated completion is 2027-02.
What conditions does trial NCT06269926 study?
This clinical trial studies the following conditions: Cerebral Palsy, Pain, Chronic.
What interventions are being tested in trial NCT06269926?
The interventions under investigation include: Cognitive Behavioral Therapy for Chronic Pain (BEHAVIORAL).
Who is sponsoring clinical trial NCT06269926?
This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06269926 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06269926's enrollment target sits among peer trials
14 76th of 91 higher than 15 of 91 other Cerebral Palsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Motor Training for Infants With Cerebral Palsy
RECRUITING · NA
-
Implementation of Therapy Together
RECRUITING · NA
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy
RECRUITING · NA
-
Neuromodulation of the Cortex and Spinal Cord
RECRUITING · NA
-
Effectiveness of Robotic Gait Training and Physical Therapy for Children and Youth With Cerebral Palsy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy